A. Tannapfel

Perioperative chemotherapy with docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) for resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma (FLOT4-AIO): A multicenter, randomized phase 3 trial

J. Trojan, G. Folprecht, M. Schuler, 2017, Zeitschrift für Gastroenterologie.

Hypoxia-Induced Tumour Cell Migration in an in vivo Chicken Model

N. Cordes, A. Tannapfel, L. Plasswilm, 2000, Pathobiology.

Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans

W. Uhl, A. Tannapfel, R. Bonadonna, 2012, Diabetologia.

The BH3-only member Noxa causes apoptosis in melanoma cells by multiple pathways

K. Schulze-Osthoff, F. Essmann, A. Tannapfel, 2008, Oncogene.

[Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease. Grade 2 consensus-based guidelines].

P. Schirmacher, H. Denk, C. Langner, 2010, Der Pathologe.

Inverse association of p16INK4a and p14ARF methylation of the CDKN2a locus in different Gleason scores of prostate cancer

B. Verdoodt, R. Palisaar, F. Sommerer, 2011, Prostate Cancer and Prostatic Diseases.

Determinants of glucose control in patients with chronic pancreatitis

W. Uhl, A. Tannapfel, W. Schmidt, 2010, Diabetologia.

mFOLFOXIRI + Panitumumab versus FOLFOXIRI as first-line treatment in patients with RAS wild- type metastatic colorectal cancer m(CRC): a randomized phase II VOLFI trial of the AIO (AIO- KRK0109).

V. Heinemann, T. Seufferlein, U. Martens, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.